Our results indicate that MixTCRpred offers a robust framework for in silico analysis of epitope-specific T cells directly from TCR repertoires and reveals enrichment of T cells predicted to be specific for the immunodominant DPB1*04:01,TFEYVSQPFLMDL epitope in COVID-19-positive patients. The gene discussed is HLA-DPB1; the disease is COVID-19.